chartexchange

XLO
Xilio Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 17, 2026 9:30:00 AM EST
7.80USD+3.515%(+0.26)8,083
After-hoursNov 18, 2026 4:00:30 PM EST
7.63USD-2.242%(-0.17)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Waltham, MA, USA
Previous Close
$7.54
Beta
0.86
52-Week High
$11.30 2025-11-19
52-Week Low
$6.47 2026-03-12
SMA 50
$8.64
SMA 200
$8.48
Avg. Vol 10D
9,445
Avg. Vol 30D
13,783
Avg. Vol 90D
16,861
Relative Vol
0.62
2.53M
6.0600%
886
Mar 16, 2026 · 1-for-14 (reverse)
XLO Profile

xilio is a waltham, massachusetts-based biopharmaceutical company focused on defeating cancer. the company's proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, xilio, derived from the latin term, ex nihilo, meaning creation or big-bang. xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. to learn more, please visit www.xiliotx.com.

XLO Performance
PeriodPriceDateChangeBeta
1W8.472026-11-11-11.22%1.389
1M8.332026-10-19-9.72%1.084
3M9.502026-08-18-20.84%1.011
6M8.152026-05-18-7.73%0.868
1Y10.502025-11-18-28.38%0.862
2Y13.612024-11-18-44.76%—
5Y340.062021-11-18-97.79%0.886
XLO Stock Summary

Xilio Therapeutics, Inc. Common Stock (NASDAQ:XLO) stock price today is $7.52, and today's volume is 8,548. XLO is down 0.265% today. The 30 day average volume is 13,783. XLO market cap is $53.12M with 7.06M shares outstanding.